On March 13, 2017, Louis A. Bianco resigned as the Executive Vice President, Finance and Administration, Chief Governance Officer and Secretary of CTI BioPharma Corp. effective immediately. Bruce J. Seeley, the company’s Executive Vice President, Chief Commercial Officer, will serve as the principal financial officer of the company, effective immediately, and will assume the title of Executive Vice President, Chief Commercial and Administrative Officer and Secretary. Mr. Seeley, 53, assumed his role as the Company’s Executive Vice President and Chief Commercial Officer in July 2015. Mr. Seeley previously served as Senior Vice President and General Manager, Diagnostics at NanoString Technologies Inc. from May 2012 to March 2015.